Proficio Capital Partners’s Legend Biotech LEGN Stock Holding History

Proficio Capital Partners’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,000	Closed	-$202K	–	317
2023 Q3	$202K	Hold	3,000	–	–	0.03%	285
2023 Q2	$207K	Sell	3,000 -2,000	-40%	-$131K	0.03%	275
2023 Q1	$241K	Hold	5,000	–	–	0.04%	247
2022 Q4	$250K	Hold	5,000	–	–	0.05%	227
2022 Q3	$204K	Hold	5,000	–	–	0.04%	243
2022 Q2	$275K	Buy	+5,000	New	+$211K	0.05%	207

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Proficio Capital Partners's LEGN Position: Q4 2023 in Review

Proficio Capital Partners sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 3,000 shares — an estimated $202K sold.

Proficio Capital Partners first reported a position in LEGN in Q2 2022 and held it in 6 quarters. The position peaked at $275K in Q2 2022. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

Proficio Capital Partners reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
Proficio Capital Partners sold 3,000 Legend Biotech shares in Q4 2023, an estimated $202K.
Proficio Capital Partners first reported a position in Legend Biotech in Q2 2022 and held it in 6 quarters.
Proficio Capital Partners's Legend Biotech position peaked at $275K in Q2 2022.
206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Proficio Capital Partners's 13F filing for Q4 2023, filed 13 Feb 2024.